Ivermectin for Treatment of COVID-19?
Hemat
Abd El Salam Ahmed Salama (1)
Mohamed Abd El-Rahman Hassan El-Shayeb (2)
Ahmed
Nour El-Din Hassan (3,4)
Ghada Essam El-Din Amin (1,5)
Mohamed
Farouk Allam (1)
Eman
El- Sayed Ahmed (2)
1.
Department of Family Medicine, Faculty of Medicine, Ain Shams University,
Cairo, Egypt.
2.
Department of Internal Medicine, Faculty of Medicine, Ain Shams University,
Cairo, Egypt.
3.
Department of Clinical Pharmacology, Faculty of Medicine, Ain Shams University,
Cairo, Egypt.
4.
Department of Clinical Pharmacology, Faculty of Medicine, Galala University,
Cairo, Egypt.
5.
Department of Community Medicine, Faculty of Medicine, 6th of October
University, Cairo, Egypt.
World Journal of
Medical Microbiology, 2022, 1, 474
DOI:
10.31586/wjmm.2022.474
Abstract:
Many
attempts have been made to repurpose existing and approved drugs for the
treatment of COVID-19 infection. This involves anti-malarial drugs such as
hydroxychloroquine and chloroquine, which have been shown to be less successful
than initially believed, with a substantial risk of often fatal complications
and interactions. This also involves Remdesivir, which has been shown to
decrease recovery time significantly in hospitalized patients. However, for
patients who are not yet hospitalized, there is no currently accepted
treatment. Treating patients before they need to be admitted or even
prophylactically could greatly decrease the load on hospitals, protect
healthcare workers and reduce the spread of COVID-19. An in-vitro study
indicated that Ivermectin was dynamic against COVID-19-infected cell.
Ivermectin has antimicrobial, antiviral, and anticancer, immunomodulatory
properties. This drug could reduce the viral load in COVID-9 infected patients,
with potential effect on disease progression and spread. Therefore, Ivermectin
may be a therapeutic choice for treatment of COVID-19, however, there is still
a lack of evidence-based studies to support ivermectin treatment of patients
with COVID-19.
Keywords: Coronavirus, COVID-19, Ivermectin,
Treatment, Review.
World Journal of
Medical Microbiology, 2022, 1, 474
https://www.scipublications.com/journal/index.php/wjmm/article/view/474
No hay comentarios:
Publicar un comentario
Nota: solo los miembros de este blog pueden publicar comentarios.